ZyVersa raises ~$2M in private placement; special meeting adjourned without quorum

ZyVersa Therapeutics, Inc.

Gross proceeds of $2M from private placement of pre-funded and common warrants; pre-funded warrants priced at $0.9499.
Common warrants exercisable at $1.00/share, expire 5 years after stockholder approval.
Existing warrants from Nov 2024 amended to reduce exercise price to $1.00 per share.
Special meeting on Mar 4 lacked quorum; proposals move to 2025 annual meeting set for June 11, 2025.
Record date for 2025 annual meeting is April 15, 2025; stockholder proposals due by March 17, 2025.

item 1.01 item 3.02 item 5.07 item 8.01 item 5.08 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.